LOADING
Comparing Pfizer Inc (PFE) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | QCOM |
|---|---|---|
| Price | $25.01 | $147.61 |
| Change Today | +0.40% | -2.63% |
| Market Cap | $143.3B | $155.0B |
| P/E Ratio | 19.1 | 16.9 |
| Forward P/E | 8.5 | 14.0 |
| PEG Ratio | 2.94 | 0.63 |
| EPS | $1.31 | $8.75 |
| Revenue Growth (YoY) | 5.4% | -4.0% |
| Profit Margin | 11.8% | 21.0% |
| Return on Equity | 8.3% | 33.8% |
| Dividend Yield | 6.90% | 2.37% |
| Beta | 0.31 | 1.64 |
| 52-Week High | $27.80 | $258.96 |
| 52-Week Low | $21.87 | $121.54 |
| Volume | 45.1M | 13.8M |
Qualcomm Inc is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.